These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19783283)
1. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study. Barillari G; Frigo MG; Casarotto M; Farnia A; Massè B; Wetzl R; Bianchin A; Rabi A; Malacarne P; Pasca S; Bigotto E; Thromb Res; 2009 Dec; 124(6):e41-7. PubMed ID: 19783283 [TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152 [TBL] [Abstract][Full Text] [Related]
4. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Ahonen J; Jokela R; Korttila K Acta Anaesthesiol Scand; 2007 Aug; 51(7):929-36. PubMed ID: 17488316 [TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322 [TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M; Crit Care; 2006; 10(6):R178. PubMed ID: 17184516 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. Berkhof FF; Eikenboom JC Transfusion; 2009 Mar; 49(3):570-7. PubMed ID: 19040498 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort. Chauleur C; Cochery-Nouvellon E; Mercier E; Aya G; Marès P; Mismetti P; Lissalde-Lavigne G; Gris JC Thromb Haemost; 2008 Nov; 100(5):773-9. PubMed ID: 18989520 [TBL] [Abstract][Full Text] [Related]
10. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023 [TBL] [Abstract][Full Text] [Related]
11. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients. Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865 [TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684 [TBL] [Abstract][Full Text] [Related]
14. Activated recombinant factor VII in orthotopic liver transplantation. Pugliese F; Ruberto F; Summonti D; Perrella S; Cappannoli A; Tosi A; D'alio A; Bruno K; Martelli S; Celli P; Morabito V; Rossi M; Berloco PB; Pietropaoli P Transplant Proc; 2007; 39(6):1883-5. PubMed ID: 17692642 [TBL] [Abstract][Full Text] [Related]
16. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation. Fischer D; Schloesser R; Buxmann H; Veldman A J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565 [TBL] [Abstract][Full Text] [Related]
17. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866 [TBL] [Abstract][Full Text] [Related]
18. The role of recombinant activated factor VII in obstetric hemorrhage. Ahonen J Curr Opin Anaesthesiol; 2012 Jun; 25(3):309-14. PubMed ID: 22473215 [TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM; Easley RB; Tobias JD Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833 [TBL] [Abstract][Full Text] [Related]
20. Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology. Murakami M; Kobayashi T; Kubo T; Hata T; Takeda S; Masuzaki H J Obstet Gynaecol Res; 2015 Aug; 41(8):1161-8. PubMed ID: 26013425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]